Piceatannol attenuates fat accumulation and oxidative stress in steatosis-induced HepG2 cells

Albano, 2005, Role of oxidative stress in the progression of non-alcoholic steatosis, Aliment. Pharmacol. Ther., 22, 71, 10.1111/j.1365-2036.2005.02601.x Alkhouri, 2009, Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal, Expet Rev. Gastroenterol. Hepatol., 3, 445, 10.1586/egh.09.32 Andrade, 2014, Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation, Nutrition, 30, 915, 10.1016/j.nut.2013.11.016 Ashikawa, 2002, Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation, J. Immunol., 169, 6490, 10.4049/jimmunol.169.11.6490 Baylin, 2002, Adipose tissue biomarkers of fatty acid intake, Am. J. Clin. Nutr., 76, 750, 10.1093/ajcn/76.4.750 Bechmann, 2012, The interaction of hepatic lipid and glucose metabolism in liver diseases, J. Hepatol., 56, 952, 10.1016/j.jhep.2011.08.025 Bost, 2005, The role of MAPKs in adipocyte differentiation and obesity, Biochimie, 87, 51, 10.1016/j.biochi.2004.10.018 Buzzetti, 2016, The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD), Metabolism, 65, 1038, 10.1016/j.metabol.2015.12.012 Chen, 2018, Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis, Life Sci., 203, 291, 10.1016/j.lfs.2018.04.022 Cordova-Gomez, 2013, Piceatannol, a better peroxyl radical scavenger than resveratrol, RSC Adv., 3, 20209, 10.1039/c3ra42923g Cousin, 2001, Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1, Endocrinology, 142, 229, 10.1210/endo.142.1.7863 Das, 2007, Anti-inflammatory responses of resveratrol, Inflamm. Allergy - Drug Targets, 6, 168, 10.2174/187152807781696464 de la Lastra, 2007, Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications, Biochem. Soc. Trans., 35, 1156, 10.1042/BST0351156 Gehlert, 1990, Stilbene synthase from seedlings of Pinus sylvestris: purification and induction in response to fungal infection, Mol. Plant Microbe Interact., 3, 444, 10.1094/MPMI-3-444 Gerets, 2012, Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins, Cell Biol. Toxicol., 28, 69, 10.1007/s10565-011-9208-4 Gomez-Lechon, 2007, A human hepatocellular in vitro model to investigate steatosis, Chem. Biol. Interact., 165, 106, 10.1016/j.cbi.2006.11.004 Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218 Jiao, 2013, Hepatic ERK activity plays a role in energy metabolism, Mol. Cell. Endocrinol., 375, 157, 10.1016/j.mce.2013.05.021 Kalaany, 2006, LXRS and FXR: the yin and yang of cholesterol and fat metabolism, Annu. Rev. Physiol., 68, 159, 10.1146/annurev.physiol.68.033104.152158 Kim, 1989, Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis, Faseb. J., 3, 2250, 10.1096/fasebj.3.11.2570725 Kim, 2011, Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice, Biochem. Pharmacol., 81, 1343, 10.1016/j.bcp.2011.03.012 Kim, 2014, Permethrin alters adipogenesis in 3T3-L1 adipocytes and causes insulin resistance in C2C12 myotubes, J. Biochem. Mol. Toxicol., 28, 418, 10.1002/jbt.21580 Ku, 2005, Production of stilbenoids from the callus of Arachis hypogaea: a novel source of the anticancer compound piceatannol, J. Agric. Food Chem., 53, 3877, 10.1021/jf050242o Kwon, 2012, Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation, J. Biol. Chem., 287, 11566, 10.1074/jbc.M111.259721 Lebel, 1992, Evaluation of the probe 2’,7’-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress, Chem. Res. Toxicol., 5, 227, 10.1021/tx00026a012 Lee, 1998, Evaluation of the antioxidant potential of natural products, Comb. Chem. High Throughput Screen., 1, 35, 10.2174/138620730101220118151526 Les, 2016, Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties, Chem-Bio Interact., 258, 115, 10.1016/j.cbi.2016.07.014 Lin, 2010, A simple and sensitive HPLC-UV method for the quantification of piceatannol analog trans-3, 5, 3′, 4′-tetramethoxystilbene in rat plasma and its application for a pre-clinical pharmacokinetic study, J. Pharmaceut. Biomed. Anal., 51, 679, 10.1016/j.jpba.2009.09.024 Liu, 2010, The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD), Lipids Health Dis., 9, 10.1186/1476-511X-9-42 Liu, 2014, Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction, Biochem. Biophys. Res. Commun., 450, 117, 10.1016/j.bbrc.2014.05.072 Livingston, 2015, The antioxidant and DNA repair activities of resveratrol, piceatannol, and pterostilbene, J. Food Res., 4, 9 Martindale, 2002, Cellular response to oxidative stress: signaling for suicide and survival, J. Cell. Physiol., 192, 1, 10.1002/jcp.10119 Muoio, 2002, Peroxisome proliferator-activated receptor-α regulates fatty acid utilization in primary human skeletal muscle cells, Diabetes, 51, 901, 10.2337/diabetes.51.4.901 Ou, 2001, Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR, Proc. Natl. Acad. Sci. U. S. A., 98, 6027, 10.1073/pnas.111138698 Reddy, 2001, Nonalcoholic steatosis and steatohepatitis - III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis, Am. J. Physiol. Gastrointest. Liver Physiol., 281, G1333, 10.1152/ajpgi.2001.281.6.G1333 Ricchi, 2009, Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes, J. Gastroenterol. Hepatol., 24, 830, 10.1111/j.1440-1746.2008.05733.x Rolo, 2012, Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis, Free Radic. Biol. Med., 52, 59, 10.1016/j.freeradbiomed.2011.10.003 Romero-Gómez, 2017, Treatment of NAFLD with diet, physical activity and exercise, J. Hepatol., 67, 829, 10.1016/j.jhep.2017.05.016 Sassa, 1987, Drug-metabolism by the human hepatoma-cell, hep G2, Biochem. Biophys. Res. Commun., 143, 52, 10.1016/0006-291X(87)90628-0 Schadinger, 2005, PPAR gamma 2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes, Am. J. Physiol. Endocrinol. Metab., 288, E1195, 10.1152/ajpendo.00513.2004 Sekiya, 2008, Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells, Biochem Biophys Res, 375, 602, 10.1016/j.bbrc.2008.08.068 Setoguchi, 2014, Absorption and metabolism of piceatannol in rats, J. Agric. Food Chem., 62, 2541, 10.1021/jf404694y Shang, 2008, Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase, Acta Pharmacol. Sin., 29, 698, 10.1111/j.1745-7254.2008.00807.x Shen, 2017, Piceatannol extends the lifespan of Caenorhabditis elegans via DAF-16, Biofactors, 43, 379, 10.1002/biof.1346 Shen, 2017, Piceatannol reduces fat accumulation in Caenorhabditis elegans, J. Med. Food, 20, 887, 10.1089/jmf.2016.0179 Shimano, 1999, Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes, J. Biol. Chem., 274, 35832, 10.1074/jbc.274.50.35832 Spahis, 2017, Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis, Antioxidants Redox Signal., 26, 519, 10.1089/ars.2016.6776 Sun, 2016, Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice, Lipids Health Dis., 15, 202, 10.1186/s12944-016-0370-9 Tang, 2015, Resveratrol ameliorates lipid accumulation in HepG2 cells, associated with down-regulation of lipin1 expression, Can. J. Physiol. Pharmacol., 94, 185, 10.1139/cjpp-2015-0125 Tilg, 2010, Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease, Minerva Gastroenterol. Dietol., 56, 159 Tung, 2016, Piceatannol exerts anti-obesity effects in C57BL/6 mice through modulating adipogenic proteins and gut microbiota, Molecules, 21, 1419, 10.3390/molecules21111419 Wang, 2015, Transcriptional regulation of hepatic lipogenesis, Nat. Rev. Mol. Cell Biol., 16, 678, 10.1038/nrm4074 Yang, 2010, Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease, Hepatol Int, 4, 741, 10.1007/s12072-010-9202-6 Yang, 2016, Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation, Sci. Rep., 6 Zhang, 2016, Efficacy of resveratrol supplementation against non-alcoholic fatty liver disease: a meta-analysis of placebo-controlled clinical trials, PloS One, 11